Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionRecombinant DNA vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentApproved
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B virus (HBV) infection; Prevent hepatitis B virus (HBV) infection for patients with renal insufficiency
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today